D4476, a cell‐permeant inhibitor of CK1, suppresses the site‐specific phosphorylation and nuclear exclusion of FOXO1a
Open Access
- 1 January 2004
- journal article
- research article
- Published by Springer Science and Business Media LLC in EMBO Reports
- Vol. 5 (1), 60-65
- https://doi.org/10.1038/sj.embor.7400048
Abstract
The protein kinase CK1 phosphorylates serine residues that are located close to another phosphoserine in the consensus pSer‐Xaa‐Xaa‐Ser. This specificity generates regions in its target proteins containing two or more neighbouring phosphoserine residues, termed here multisite phosphorylation domains (MPDs). In this paper, we demonstrate that D4476 is a potent and rather selective inhibitor of CK1 in vitro and in cells. In H4IIE hepatoma cells, D4476 specifically inhibits the phosphorylation of endogenous forkhead box transcription factor O1a (FOXO1a) on Ser322 and Ser325 within its MPD, without affecting the phosphorylation of other sites. Our results indicate that these residues are targeted by CK1 in vivo and that the CK1‐mediated phosphorylation of the MPD is required for accelerated nuclear exclusion of FOXO1a in response to IGF‐1 and insulin. D4476 is much more potent and specific than IC261 or CKI‐7, and is therefore the most useful CK1 inhibitor currently available for identifying physiological substrates of CK1.Keywords
This publication has 31 references indexed in Scilit:
- The specificities of protein kinase inhibitors: an updateBiochemical Journal, 2003
- Effect of multiple phosphorylation events on the transcription factors FKHR, FKHRLI and AFXBiochemical Society Transactions, 2002
- Identification of Novel Inhibitors of the Transforming Growth Factor β1 (TGF-β1) Type 1 Receptor (ALK5)Journal of Medicinal Chemistry, 2002
- Roles of the forkhead in rhabdomyosarcoma (FKHR) phosphorylation sites in regulating 14-3-3 binding, transactivation and nuclear targettingBiochemical Journal, 2001
- Molecular interaction of dihydropyridine receptors with type-1 ryanodine receptors in rat brainBiochemical Journal, 2001
- Specificity and mechanism of action of some commonly used protein kinase inhibitorsBiochemical Journal, 2000
- Nuclear Entry of the Circadian Regulator mPER1 Is Controlled by Mammalian Casein Kinase I ɛMolecular and Cellular Biology, 2000
- Crystal Structure of a Conformation-selective Casein Kinase-1 InhibitorJournal of Biological Chemistry, 2000
- Phosphorylation Meets Ubiquitination: The Control of NF-κB ActivityAnnual Review of Immunology, 2000
- Analysis of the in vivo phosphorylation state of rabbit skeletal muscle glycogen synthase by fast‐atom‐bombardment mass spectrometryEuropean Journal of Biochemistry, 1988